These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 990049)

  • 21. [Importance of surface active substances in the lung].
    Kadlec K; Kandus J
    Vnitr Lek; 1972 Jun; 18(6):521-31. PubMed ID: 5068058
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pulmonary surface-active factor (surfactant) in respiratory tract diseases].
    Puchkov GF; Iazvinskiĭ II
    Sov Med; 1975 Aug; (8):62-6. PubMed ID: 788185
    [No Abstract]   [Full Text] [Related]  

  • 23. Respiratory distress syndrome--new therapeutic approaches to a complex pathophysiology.
    Jobe A
    Adv Pediatr; 1983; 30():93-130. PubMed ID: 6369946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new look at the treatment of hyaline membrane disease.
    Gluck L
    Mead Johnson Symp Perinat Dev Med; 1978; (14):59-65. PubMed ID: 583438
    [No Abstract]   [Full Text] [Related]  

  • 25. [Physiological aspects of the respiratory distress syndrome (report) (author's transl)].
    Schoedel W
    Verh Dtsch Ges Pathol; 1971; 55():2-12. PubMed ID: 4130726
    [No Abstract]   [Full Text] [Related]  

  • 26. The era of pulmonary surfactant from Laplace to nowadays.
    Parmigiani S; Solari E
    Acta Biomed; 2003 Aug; 74(2):69-75. PubMed ID: 14509914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perspectives on respiratory distress syndrome of the newborn.
    Polak MJ; Polak JD; Bucciarelli RL
    Compr Ther; 1989 Dec; 15(12):28-34. PubMed ID: 2691189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of surfactant in the prevention and treatment of neonatal respiratory distress syndrome.
    Reynolds MS; Wallander KA
    Clin Pharm; 1989 Aug; 8(8):559-76. PubMed ID: 2670398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the alveolar lining layer of the lungs: some biological and pathological aspects.
    Groniowski J
    Acta Med Pol; 1971; 12(3):303-17. PubMed ID: 5170918
    [No Abstract]   [Full Text] [Related]  

  • 30. Surfactant and RDS in premature infants.
    Lynch RG
    FASEB J; 2004 Oct; 18(13):1624. PubMed ID: 15466362
    [No Abstract]   [Full Text] [Related]  

  • 31. [Idiopathic respiratory distress syndrome in premature infants].
    Weisser K
    Anaesthesist; 1970 Mar; 19(3):101-5. PubMed ID: 5534396
    [No Abstract]   [Full Text] [Related]  

  • 32. Pulmonary surfactant: an interdisciplinary approach.
    Notter RH; Finkelstein JN
    J Appl Physiol Respir Environ Exerc Physiol; 1984 Dec; 57(6):1613-24. PubMed ID: 6392226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Composition and function of pulmonary surfactant and its implication in respiratory distress syndrome of the neonate.
    Morris DC
    Ohio Med; 1990 Jul; 86(7):547-50. PubMed ID: 2392271
    [No Abstract]   [Full Text] [Related]  

  • 34. Lung surfactant--a natural detergent.
    Horwitz C
    S Afr Med J; 1972 Dec; 46(49):1931-2. PubMed ID: 4678923
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pulmonary surfactant: anti-atelectasis factor].
    Ouellet Y
    Laval Med; 1970 May; 41(5):627-30. PubMed ID: 4928481
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pulmonary surfactan. Current physiological and physiopathological concepts].
    Pariente R
    Presse Med (1893); 1969 Nov; 77(50):1871-2. PubMed ID: 5197179
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunohistochemical study of human pulmonary surfactant apoproteins with monoclonal antibodies. Pathologic application for hyaline membrane disease.
    Kuroki Y; Dempo K; Akino T
    Am J Pathol; 1986 Jul; 124(1):25-33. PubMed ID: 3524252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The surfactant system of the lung as a functional unit].
    von Seefeld H; Weiss JM; Rensch H
    Fortschr Med; 1984 Oct; 102(39):977-81. PubMed ID: 6389289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The therapeutic use of pulmonary surfactant in neonatal hyaline membrane disease].
    Lozano-González CH; Piña-Ceballos VM; Beyer-Obezo J; Gutiérrez-Martín A; Martínez-Hinojosa B; Flores-Támez ME
    Bol Med Hosp Infant Mex; 1993 Jul; 50(7):481-91. PubMed ID: 8363747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The exogenous surfactant and its effect on the respiratory distress syndrome (RDS)].
    Brabec R; Zoban P; Tomásová H
    Cesk Fysiol; 1996 Sep; 45(3):139-45. PubMed ID: 8974827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.